Widmann Financial Services, Inc. Synthetic Biologics, Inc. Call Options Transaction History

Widmann Financial Services, Inc.

  • $132 Million
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

About Synthetic Biologics, Inc.

SYN Quotes by TradingView
  • Ticker SYN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,844,100
  • Market Cap $9.51M
  • Description
  • Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...
More about SYN
Track This Portfolio

Track Widmann Financial Services, Inc. Portfolio

Follow Widmann Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Widmann Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Widmann Financial Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email